Literature DB >> 28508978

Acute tumoral calcinosis due to severe hyperphosphatemia in a maintenance hemodialysis patient.

Keizo Nishime1, Hiroki Takahashi2.   

Abstract

We report the case of a maintenance hemodialysis patient with severe hyperphosphatemia (26.6 mg/dL) who developed acute tumoral calcinosis. The patient started receiving maintenance hemodialysis after being diagnosed with type 2 diabetes mellitus. The patient's phosphate levels suddenly increased. He had not taken the prescribed phosphate binders for the past 5 years. He noticed swelling of the palmar aspects of his right thumb, which was diagnosed as tumoral calcinosis. His serum phosphate level reached 26.6 mg/dL. He started taking medication to lower his serum phosphate levels. The patient had a long history of eating convenience foods. As food additives in convenience foods could be a major source of phosphate, the patient corrected this habit by replacing convenience foods with special foods for dialysis patients. His symptoms improved along with the decrease in his serum phosphate levels. The main reason for the abrupt decrease in phosphate levels could be the correction of his dietary habits. Therefore, phosphate levels in processed foods should be carefully considered in dialysis patients.

Entities:  

Keywords:  Acute tumoral calcinosis; Food additives; Hemodialysis; Severe hyperphosphatemia

Year:  2016        PMID: 28508978      PMCID: PMC5413758          DOI: 10.1007/s13730-016-0225-2

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  18 in total

1.  Dietary phosphate restriction normalizes biochemical and skeletal abnormalities in a murine model of tumoral calcinosis.

Authors:  Shoji Ichikawa; Anthony M Austin; Amie K Gray; Matthew R Allen; Michael J Econs
Journal:  Endocrinology       Date:  2011-10-18       Impact factor: 4.736

Review 2.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

Review 3.  The phosphate binder equivalent dose.

Authors:  John T Daugirdas; William F Finn; Michael Emmett; Glenn M Chertow
Journal:  Semin Dial       Date:  2011 Jan-Feb       Impact factor: 3.455

4.  Phosphate regulation of vascular smooth muscle cell calcification.

Authors:  S Jono; M D McKee; C E Murry; A Shioi; Y Nishizawa; K Mori; H Morii; C M Giachelli
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

Review 5.  Media calcification and intima calcification are distinct entities in chronic kidney disease.

Authors:  Kerstin Amann
Journal:  Clin J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 8.237

6.  Persistently elevated parathyroid hormone secretion and action in young women after four weeks of ingesting high phosphorus, low calcium diets.

Authors:  M S Calvo; R Kumar; H Heath
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

7.  Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients.

Authors:  Catherine M Sullivan; Janeen B Leon; Ashwini R Sehgal
Journal:  J Ren Nutr       Date:  2007-09       Impact factor: 3.655

8.  Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources.

Authors:  Richard A Sherman; Ojas Mehta
Journal:  Am J Kidney Dis       Date:  2009-04-19       Impact factor: 8.860

9.  Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?

Authors:  Christian S Shinaberger; Sander Greenland; Joel D Kopple; David Van Wyck; Rajnish Mehrotra; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

Review 10.  Discovery of alpha-Klotho unveiled new insights into calcium and phosphate homeostasis.

Authors:  Yo-ichi Nabeshima
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2009       Impact factor: 3.493

View more
  1 in total

Review 1.  Juxta-articular tumoral calcinosis associated with the temporomandibular joint: a case report and concise review.

Authors:  Yang Sha; Kanglun Hong; Melvin Kang Ming Liew; Jing Li Lum; Raymond Chung Wen Wong
Journal:  BMC Oral Health       Date:  2019-07-09       Impact factor: 2.757

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.